LSE:AVCT (Avacta Group Plc)
About AVCT
Avacta Group Plc engages in the provision of Affimer reagents for licensing into third-party research and diagnostic products, and creates new Affimer medicines for development in-house and licensing to large pharmaceutical companies. It operates through the Life Sciences and Animal Health segments. The Life Sciences segment offers custom Affimers for reagents and diagnostics, drug and biomarker discovery in biotech research and development. The Animal Health segment includes tools and contract services to assist diagnosis of conditions in animals to enable faster treatment for veterinarians. The company was founded by Alastair MacLaughlin Smith, Simon Webster, and Kurt Justin Baldwin in January 2004 and is headquartered in Leeds, the United Kingdom.
Financial Market Data copyright © 2026
QuoteMedia. Data delayed 15 minutes unless otherwise
indicated (view
delay times for all exchanges).
RT=Real-Time, EOD=End of Day,
PD=Previous Day. Market
Data powered by QuoteMedia.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Profiles by Morningstar.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Financials by Morningstar.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia. Data delayed 15 minutes unless otherwise
indicated (view
delay times for all exchanges).
RT=Real-Time, EOD=End of Day,
PD=Previous Day. Market
Data powered by QuoteMedia.
Terms of Use.
Financial Market Data copyright © 2026
QuoteMedia. Data delayed 15 minutes unless otherwise
indicated (view
delay times for all exchanges).
RT=Real-Time, EOD=End of Day,
PD=Previous Day. Market
Data powered by QuoteMedia.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Share Information by Morningstar.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Dividends by EDI/Mergent (USA) and TSX (CDN).
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Earnings and Analyst Ratings by Zacks.
Earnings Events by Wall Street Horizon.
Terms of Use.
Frequently Asked Questions
-
Avacta was listed on the London Stock Exchange Alternative Investment Market in October 2003 through a reverse takeover. The split-adjusted floating price was 5,250p.
-
No. According to the 2020 annual report, Avacta does not pay dividends to shareholders, nor has it proposed to do so in the future.
Avacta Group Plc (LSE: AVCT) Latest News
Investing Articles
The Avacta share price is up 115.9% in 6 months! Should I buy now?
Investing Articles
3 cheap, near-penny shares to consider buying in June
Investing Articles
Down 65% in 2024, but can the Avacta (AVCT) share price ever recover?
Investing Articles
Is Avacta the best ex-penny stock to buy today?
Investing Articles
Down 63% in 2024, what’s going on with the Avacta (AVCT) share price?
Investing Articles
If I’d invested £1,000 in Avacta shares 5 years ago, here’s how much I’d have now
Investing Articles
Avacta shares quadrupled in five years! Am I too late to buy?
Investing Articles
Is the Avacta share price dip a buying opportunity?
Investing Articles
Is the Avacta share price about to rocket in 2023?
Investing Articles
Can the Avacta share price make me rich?
Investing Articles
Up 173%, can Avacta shares continue this incredible run?
